[Copolymer I (COP-I) in the treatment of multiple sclerosis].
Wender
M
M
D004341:Drug Evaluation; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use* / Q000633:toxicity; D014481:United States
D010455:Peptides; C021759:(T,G)-A-L
W sprawie kopolimeru I (COP-I) w leczeniu stwardnienia rozsianego.